
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 901 | 858 | 1013 | 1142 | 1186 | 2160 |
Fund Return | -9.88% | -14.24% | 1.25% | 4.52% | 3.47% | 8% |
Place in category | 199 | 259 | 250 | 190 | 482 | 132 |
% in Category | 34 | 47 | 47 | 42 | 93 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 22.54B | 6.80 | 12.02 | 7.94 | ||
Artisan International Value Advisor | 11.43B | 6.74 | 11.91 | 7.85 | ||
Artisan Mid Cap Advisor | 3.59B | -6.33 | 4.41 | 8.60 | ||
Artisan Mid Cap Institutional | 3.59B | -6.27 | 4.51 | 8.70 | ||
Artisan Mid Cap Investor | 3.59B | -6.37 | 4.27 | 8.44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Explorer Adm | 16.56B | -10.62 | 3.46 | 8.50 | ||
Vanguard Small Cap Growth Index Adm | 12.66B | -11.17 | 4.69 | 7.38 | ||
Neuberger Berman Genesis R6 | 4.37B | -10.64 | 4.18 | 8.33 | ||
T. Rowe Price Instl Small-Cap Stock | 4.25B | -7.07 | 4.92 | 8.88 | ||
T. Rowe Price QM US Small-Cap Gr Eq | 4.26B | -7.75 | 7.16 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ascendis Pharma AS | US04351P1012 | 5.67 | 157.60 | +0.04% | |
Guidewire | US40171V1008 | 4.56 | 217.03 | +0.86% | |
Lattice | US5184151042 | 3.51 | 52.53 | +0.54% | |
MACOM Tech | US55405Y1001 | 2.93 | 123.46 | +0.76% | |
Halozyme | US40637H1095 | 2.69 | 52.02 | +6.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Neutral | Strong Sell |
Summary | Strong Buy | Neutral | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review